Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Global Scientific Production on Illicit Drug Addiction: A Two-Decade Analysis Publisher Pubmed



Khalili M1 ; Rahimimovaghar A2 ; Shadloo B2 ; Mojtabai R3 ; Mann K4 ; Aminesmaeili M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, No. 486, South Karegar Ave., Tehran, 1336616357, Iran
  3. 3. Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States
  4. 4. Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany

Source: European Addiction Research Published:2018


Abstract

Aims: Addiction science has made great progress in the past decades. We conducted a scientometric study in order to quantify the number of publications and the growth rate globally, regionally, and at country levels. Methods: In October 2015, we searched the Scopus database using the general keywords of addiction or drug-use disorders combined with specific terms regarding 4 groups of illicit drugs-cannabis, opioids, cocaine, and other stimulants or hallucinogens. All documents published during the 20-year period from 1995 to 2014 were included. Results: A total of 95,398 documents were retrieved. The highest number of documents were on opioids, both globally (60.1%) and in each of 5 continents. However, studies on cannabis showed a higher growth rate in the last 5-year period of the study (2010-2014). The United States, the United Kingdom, Germany, Canada, Australia, France, Spain, Italy, China, and Japan- A lmost all studies were from high-income countries-occupied the top 10 positions and produced 81.4% of the global science on drug addiction. Conclusion: As there are important socio-cultural differences in the epidemiology and optimal clinical care of addictive disorders, it is suggested that low- A nd more affected middle-income countries increase their capacity to conduct research and disseminate the knowledge in this field. © 2018 S. Karger AG, Basel. All rights reserved.